eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
6/2016
vol. 20
 
Share:
Share:
abstract:
Review paper

Can high dose rates used in cancer radiotherapy change therapeutic effectiveness?

Maria Konopacka
,
Jacek Rogoliński
,
Aleksander Sochanik
,
Krzysztof Ślosarek

Contemp Oncol (Pozn) 2016; 20 (1): 449–452
Online publish date: 2017/01/30
View full text Get citation
 
PlumX metrics:
Current cancer radiotherapy relies on increasingly high dose rates of ionising radiation (100–2400 cGy/min). It is possible that changing dose rates is not paralleled by treatment effectiveness.

Irradiating cancer cells is assumed to induce molecular alterations that ultimately lead to apoptotic death. Studies comparing the efficacy of radiation-induced DNA damage and apoptotic death in relation to varying dose rates do not provide unequivocal data. Whereas some have demonstrated higher dose rates (single dose) to effectively kill cancer cells, others claim the opposite. Recent gene expression studies in cells subject to variable dose rates stress alterations in molecular signalling, especially in the expression of genes linked to cell survival, immune response, and tumour progression. Novel irradiation techniques of modern cancer treatment do not rely anymore on maintaining absolute constancy of dose rates during radiation emission: instead, timing and exposure areas are regulated temporally and spatially by modulating the dose rate and beam shape. Such conditions may be reflected in tumour cells’ response to irradiation, and this is supported by the references provided.
keywords:

cancer radiotherapy, ionising radiation, dose rate, apoptosis, genetic damage, gene expression profile

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.